186 related articles for article (PubMed ID: 38762268)
1. Unleashing the power of antibodies: Engineering for tomorrow's therapy.
Sagar ; Takhellambam M; Rattan A; Prajapati VK
Adv Protein Chem Struct Biol; 2024; 140():1-36. PubMed ID: 38762268
[TBL] [Abstract][Full Text] [Related]
2. Engineering of therapeutic antibodies to minimize immunogenicity and optimize function.
Presta LG
Adv Drug Deliv Rev; 2006 Aug; 58(5-6):640-56. PubMed ID: 16904789
[TBL] [Abstract][Full Text] [Related]
3. Antibody Engineering for Pursuing a Healthier Future.
Saeed AF; Wang R; Ling S; Wang S
Front Microbiol; 2017; 8():495. PubMed ID: 28400756
[TBL] [Abstract][Full Text] [Related]
4. The biotechnology and applications of antibody engineering.
Rapley R
Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
[TBL] [Abstract][Full Text] [Related]
5. Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display.
Kuhn P; Fühner V; Unkauf T; Moreira GM; Frenzel A; Miethe S; Hust M
Proteomics Clin Appl; 2016 Oct; 10(9-10):922-948. PubMed ID: 27198131
[TBL] [Abstract][Full Text] [Related]
6. Engineered anti-CD70 antibody with multiple effector functions exhibits in vitro and in vivo antitumor activities.
McEarchern JA; Oflazoglu E; Francisco L; McDonagh CF; Gordon KA; Stone I; Klussman K; Turcott E; van Rooijen N; Carter P; Grewal IS; Wahl AF; Law CL
Blood; 2007 Feb; 109(3):1185-92. PubMed ID: 17038522
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies: technologies for early discovery and engineering.
Kennedy PJ; Oliveira C; Granja PL; Sarmento B
Crit Rev Biotechnol; 2018 May; 38(3):394-408. PubMed ID: 28789584
[TBL] [Abstract][Full Text] [Related]
8. Antibodies for therapeutic uses and the evolution of biotechniques.
Nieri P; Donadio E; Rossi S; Adinolfi B; Podestà A
Curr Med Chem; 2009; 16(6):753-79. PubMed ID: 19199935
[TBL] [Abstract][Full Text] [Related]
9. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
10. Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy.
Unkauf T; Miethe S; Fühner V; Schirrmann T; Frenzel A; Hust M
Adv Exp Med Biol; 2016; 917():55-76. PubMed ID: 27236552
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments.
Lee W; Lee SM; Jung ST
BioDrugs; 2023 Sep; 37(5):637-648. PubMed ID: 37486566
[TBL] [Abstract][Full Text] [Related]
12. Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.
Loureiro LR; Carrascal MA; Barbas A; Ramalho JS; Novo C; Delannoy P; Videira PA
Biomolecules; 2015 Aug; 5(3):1783-809. PubMed ID: 26270678
[TBL] [Abstract][Full Text] [Related]
13. Antibody engineering and modification technologies.
Filpula D
Biomol Eng; 2007 Jun; 24(2):201-15. PubMed ID: 17466589
[TBL] [Abstract][Full Text] [Related]
14. Full-length recombinant antibodies from
Rashid MH
MAbs; 2022; 14(1):2111748. PubMed ID: 36018829
[TBL] [Abstract][Full Text] [Related]
15. Engineering antibodies for therapy.
Adair JR
Immunol Rev; 1992 Dec; 130():5-40. PubMed ID: 1286872
[TBL] [Abstract][Full Text] [Related]
16. Antibody therapeutics, antibody engineering, and the merits of protein stability.
Demarest SJ; Glaser SM
Curr Opin Drug Discov Devel; 2008 Sep; 11(5):675-87. PubMed ID: 18729019
[TBL] [Abstract][Full Text] [Related]
17. Discovery of novel candidate therapeutics and diagnostics based on engineered human antibody domains.
Chen W; Gong R; Ying T; Prabakaran P; Zhu Z; Feng Y; Dimitrov DS
Curr Drug Discov Technol; 2014 Mar; 11(1):28-40. PubMed ID: 23863097
[TBL] [Abstract][Full Text] [Related]
18. Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies.
Rickert KW; Grinberg L; Woods RM; Wilson S; Bowen MA; Baca M
MAbs; 2016; 8(3):501-12. PubMed ID: 26852694
[TBL] [Abstract][Full Text] [Related]
19.
André AS; Moutinho I; Dias JNR; Aires-da-Silva F
Front Microbiol; 2022; 13():962124. PubMed ID: 36225354
[TBL] [Abstract][Full Text] [Related]
20. IBC's 21st Annual Antibody Engineering and 8th Annual Antibody Therapeutics International Conferences and 2010 Annual Meeting of the Antibody Society. December 5-9, 2010, San Diego, CA USA.
Arnett SO; Teillaud JL; Wurch T; Reichert JM; Dunlop C; Huber M
MAbs; 2011; 3(2):133-52. PubMed ID: 21304271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
